Lyophilization Does Not Inactivate Infectious Retrovirus in Systemically Infected Bone and Tendon Allografts

American Journal of Sports Medicine

Volumn 32, Issue 3, 2004, Pages 580-586

  Crawford, Matthew J ^a   Swenson, Cheryl L ^b   Arnoczky, Steven P ^a,b   O'Shea, Jeremy ^a   Ross, Herbert ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Allograft; Bone; Lyophilization; Retrovirus; Tendon

Indexed keywords

NUCLEIC ACID; PROTEIN P27; VIRUS ANTIGEN; VIRUS DNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; BONE INFECTION; CAT; CONTROLLED STUDY; CORTICAL BONE; DNA EXTRACTION; EMBRYO; EMBRYO CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE LEUKEMIA VIRUS; FREEZE DRYING; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS; TENDON GRAFT; VIRUS INACTIVATION;

ANIMALS; ANTIGENS, VIRAL; BONE TRANSPLANTATION; CATS; CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTREMITIES; FREEZE DRYING; LEUKEMIA VIRUS, FELINE; RETROVIRIDAE INFECTIONS; TENDONS; TIBIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 1942471053     PISSN: 03635465     EISSN: None     Source Type: Journal    
DOI: 10.1177/0363546504263404     Document Type: Article

References (63)

1. AAOS and AATB Information for Patients. McLean, Va: American Association of Tissue Banks; 2003.
2. Akkus O, Rimnac CM. Fracture resistance of gamma radiation sterilized cortical bone allografts. J Orthop Res. 2001;19:927-934.
3. Anastasescou M, Cornu O, Banse X, Konig J, Hassoun A, Delloye C. Ethanol treatment of tendon allografts: a potential HIV inactivating procedure. Int Orthop. 1998;22:252-254.
4. Asselmeier MA, Caspari RB, Bottenfield S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sports Med. 1993;21:170-175.
5. Barbour SA, King W. The sage and effective use of allograft tissue: an update. Am J Sports Med. 2003;31:791-797.
6. Buck BE, Malinin TI, Brown MD. Bone transplantation and human immunodeficiency virus: an estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop. 1989;240:129-136.
7. Buck BE, Resnick L, Shah SM, Malinin TI. Human immunodeficiency virus cultured from bone: implications for transplantation. Clin Orthop. 1990;251:249-253.
8. Casey JW, Roach A, Mullins JI, et al. The U3 portion of feline leukemia virus DNA identifies horizontally acquired proviruses in leukemic cats. Proc Natl Acad Sci U S A. 1981;78:7778-7782.
9. Conrad EU, Gretch DR, Obermeyer KR, et al. Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am. 1995;77:214-224.
10. Conway B, Tomford WW. Radiosensitivity of human immunodeficiency virus type 1. Clin Infect Dis. 1992;14:978-979.
11. Coronado GS Jr, Swenson CL, Martinez SA, Burkhardt KS, Arnoczky SP. Effects of a 98% solution of glycerol or sterilization with ethylene oxide on FeLV in bone allografts and effects on bone incorporation of allografts in cats. Am J Vet Res. 2000;61:665-671.
12. De Deyne P, Haut RC. Some effects of gamma irradiation on patellar tendon allografts. Connect Tissue Res. 1991;27:51-62.
13. Diehl LJ, Hoover EA. Early and progressive helper T-cell dysfunction in feline leukemia virus-induced immunodeficiency. J Acquir Immune Defic Syndr. 1992;5:1188-1194.
14. Dodd RY, Notari EPT, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42:975-979.
15. Doherty MJ, Mollan RA, Wilson DJ. Effect of ethylene oxide sterilization on human demineralized bone. Biomaterials. 1993;14:994-998.
16. Essex M. Strategies of research for a vaccine against AIDS. Hist Philos Life Sci. 1995;17:141-149.
17. Ferreira SD, Dernell WS, Powers BE, et al. Effect of gas-plasma sterilization on the osteoinductive capacity of demineralized bone matrix. Clin Orthop. 2001;388:233-239.
18. Fideler BM, Vangsness CT Jr, Lu B, Orlando C, Moore T. Gamma irradiation: effects on biomechanical properties of human bone-patellar tendon-bone allografts. Am J Sports Med. 1995;23:643-646.
19. Fideler BM, Vangsness CT Jr, Moore T, Li Z, Rasheed S. Effects of gamma irradiation on the human immunodeficiency virus: a study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavera. J Bone Joint Surg Am. 1994;76:1032-1035.
20. Goertzen MJ, Clahsen H, Burrig KF, Schulitz KP. Sterilisation of canine anterior cruciate allografts by gamma irradiation in argon: mechanical and neurohistological properties retained one year after transplantation. J Bone Joint Surg Br. 1995;77:205-212.
21. Greiff D, Rightsel WA. Stability of suspensions of influenza virus dried to different contents of residual moisture by sublimation in vacuo. Appl Microbiol. 1968;16:835-840.
22. Hepatitis C virus transmission from an antibody-negative organ and tissue donor: United States, 2000-2002. MMWR Morb Mortal Wkly Rep. 2003;52:273-274, 276.
23. Hofmann-Lehmann R, Holznagel E, Ossent P, Lutz H. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets. Clin Diagn Lab Immunol. 1997;4:33-42.
24. Hofmann-Lehmann R, Huder JB, Gruber S, Boretti F, Sigrist B, Lutz H. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol. 2001;82:1589-1596.
25. Ijiri S, Yamamuro T, Nakamura T, Kotani S, Notoya K. Effect of sterilization on bone morphogenetic protein. J Orthop Res. 1994;12:628-636.
26. Jackson DW, Windler GE, Simon TM. Intraarticular reaction associated with the use of freeze-dried, ethylene oxide-sterilized bone-patella tendon-bone allografts in the reconstruction of the anterior cruciate ligament. Am J Sports Med. 1990;18:1-10; discussion 10-11.
27. Linenberger ML, Abkowitz JL. Haematological disorders associated with feline retrovirus infections. Baillieres Clin Haematol. 1995;8:73-112.
28. Maeda A, Inoue M, Shino K, et al. Effects of solvent preservation with or without gamma irradiation on the material properties of canine tendon allografts. J Orthop Res. 1993;11:181-189.
29. Mellonig JT, Prewett AB, Moyer MP. HIV inactivation in a bone allograft. J Periodontol. 1992;63:979-983.
30. Miyazawa T, Jarrett O. Feline leukaemia virus proviral DNA detected by polymerase chain reaction in antigenaemic but non-viraemic (" discordant") cats. Arch Virol. 1997;142:323-332.
31. Mukherji E, Au JL, Mathes LE. Differential antiviral activities and intracellular metabolism of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine in human cells. Antimicrob Agents Chemother. 1994;38:1573-1579.
32. Mullins JI, Hoover EA, Overbaugh J, Quackenbush SL, Donahue PR, Poss ML. FeLV-FAIDS-induced immunodeficiency syndrome in cats. Vet Immunol Immunopathol. 1989;21:25-37.
33. Nemzek JA, Arnoczky SP, Swenson CL. Retroviral transmission by the transplantation of connective-tissue allografts: an experimental study. J Bone Joint Surg Am. 1994;76:1036-1041.
34. Nemzek JA, Arnoczky SP, Swenson CL. Retroviral transmission in bone allotransplantation: the effects of tissue processing. Clin Orthop. 1996;324:275-282.
35. Nucleic Acid Testing: Investigations to Detect Blood Viruses More Effectively Fact Sheet. American Red Cross; 2003.
36. Overbaugh J, Bangham CR. Selection forces and constraints on retroviral sequence variation. Science. 2001;292:1106-1109.
37. Oversight of Tissue Banking. Washington, DC: US Dept of Health and Human Services, Office of the Inspector General; 2001.
38. Pan J, Zhong C, Chang Z, Roy-Burman P. A potential therapeutic strategy to combat leukemia virus infection. Cancer Biol Ther. 2003;2:92-99.
39. Pennypacker C, Perelson AS, Nys N, Nelson G, Sessler DI. Localized or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis. J Acquir Immune Defic Syndr. 1995;8:321-329.
40. Piszkiewicz D, Bourret L, Lieu M, et al. Heat inactivation of human immunodeficiency virus in lyophilized factor VIII and factor IX concentrates. Thromb Res. 1987;47:235-241.
41. Piszkiewicz D, Thomas W, Lieu M, et al. Heat inactivation of human immunodeficiency virus in lyophilized anti-inhibitor coagulant complex (Autoplex). Thromb Res. 1986;44:701-707.
42. Rasmussen TJ, Feder SM, Butler DL, Noyes FR. The effects of 4 Mrad of gamma irradiation on the initial mechanical properties of bone-patellar tendon-bone grafts. Arthroscopy. 1994;10:188-197.
43. Russell JL, Block JE. Clinical utility of demineralized bone matrix for osseous defects, arthrodesis, and reconstruction: impact of processing techniques and study methodology. Orthopedics. 1999;22:524-533.
44. Salzman NP, Psallidopoulos M, Prewett AB, O'Leary R. Detection of HIV in bone allografts prepared from AIDS autopsy tissue. Clin Orthop. 1993;292:384-390.
45. Septic arthritis following anterior cruciate ligament reconstruction using tendon allografts: Florida and Louisiana, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:1081-1083.
46. Simonds RJ. HIV transmission by organ and tissue transplantation. AIDS. 1993;7(suppl 2):S35-S38.
47. Simonds RJ, Holmberg SD, Hurwitz RL, et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med. 1992;326:726-732.
48. Smith CW, Young IS, Kearney JN. Mechanical properties of tendons: changes with sterilization and preservation. J Biomech Eng. 1996;118:56-61.
49. Smith RA, Ingels J, Lochemes JJ, Dutkowsky JP, Pifer LL. Gamma irradiation of HIV-1. J Orthop Res. 2001;19:815-819.
50. Standards for Tissue Banking. McLean, Va: American Association of Tissue Banks; 2002.
51. Strong DM, MacKenzie AP. Disease transmission, sterilization, and the clinical use of musculoskeletal tissue. In: Tomford WW, ed. Musculoskeletal Tissue Banking. New York, NY: Raven Press; 1993:209-230.
52. Swenson CL, Arnoczky SP. Demineralization inactivates infectious retrovirus in systemically infected cortical bone: in vitro and in vivo experimental studies. J Bone Joint Surg Am. 2003;85:323-332.
53. Tersmette M, de Goede RE, Over J, et al. Thermal inactivation of human immunodeficiency virus in lyophilised blood products evaluated by ID50 titrations. Vox Sang. 1986;51:239-243.
54. Tjotta E, Hungnes O, Grinde B. Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying. J Med Virol. 1991;35:223-227.
55. Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am. 1995;77:1742-1754.
56. Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep. 1988;37:597-599.
57. Unexplained deaths following knee surgery: Minnesota, November 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1035-1036.
58. Update: acquired immunodeficiency syndrome (AIDS) in persons with hemophilia. MMWR Morb Mortal Wkly Rep. 1984;33:589-591.
59. Update: allograft-associated bacterial infections: United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:207-210.
60. Update: unexplained deaths following knee surgery: Minnesota, 2001. MMWR Morb Mortal Wkly Rep. 2001;50:1080.
61. van Bueren J, Larkin DP, Simpson RA. Inactivation of human immunodeficiency virus type 1 by alcohols. J Hosp Infect. 1994;28:137-148.
62. von Garrel T, Knaepler H, Gurtler L. [Inactivation of HIV-1 in human femur heads using a heat disinfection system (Lobator SD-1)]. Unfallchirurg. 1997;100:375-381.
63. Zhao S, Consoli U, Arceci R, Pfeifer J, Dalton WS, Andreeff M. Semi-automated PCR method for quantitating MDR1 expression. Biotechniques. 1996;21:726-731.